CHRISTINE MARCELLO: Open Payments
NPI 1114487469 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,897 in 70 payments from 13 companies in 2025. Trend: 2023 $1,667 · 2024 $550 · 2025 $5,897
Food & beverage: $2,953Consulting: $2,944
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 9 | $1,947 |
| GENZYME CORPORATION | 4 | $1,911 |
| EMD Serono, Inc. | 17 | $642 |
| TG Therapeutics, Inc. | 13 | $633 |
| Biogen, Inc. | 8 | $205 |
| Amgen Inc. | 6 | $141 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Celgene Corporation | 5 | $108 |
| Merz Pharmaceuticals, LLC | 2 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
Products named: Ocrevus, BRIUMVI, TYSABRI, UPLIZNA, ZEPOSIA, AMPYRA, PONVORY, Tascenso ODT.
Industry payments across PA — which companies pay providers there.
